Blitz India Health Bureau
NEW DELHI: India’s health strategy is advancing on two fronts: widening access to care and building industrial depth in medicine. Ayushman Bharat now counts over 434 million cards issued.
The scheme’s insurance arm allocation was raised to ₹9,500 crore, and primary centres — Ayushman Arogya Mandirs — number more than 1.84 lakh nationwide. On the industrial side, the Budget launched Biopharma SHAKTI to build an end-to-end ecosystem for biologics and biosimilars.
India is widening the safety net and, at the same time, moving up the medicine value chain — from the world’s pharmacy of generics toward home-grown biologics.
At a Glance
• Ayushman cards: 434+ million issued
• PM-JAY allocation (FY27): ₹9,500 crore
• Primary centres: 1.84+ lakh Arogya Mandirs
• New: Biopharma SHAKTI; 1,000+ trial sites
Complementary initiatives — a National Mental Health Programme and integrated medical hubs — signal a broadening definition of health. International observers have pointed to Ayushman Bharat as a blueprint for equitable health systems.
The constructive priority is quality and continuity: stronger referrals, an expanded workforce, and a biopharma push that yields globally competitive, affordable innovation.
